申请人:FIBROSTATIN, S.L.
公开号:US20140080852A1
公开(公告)日:2014-03-20
Disclosed are compounds of formula:
that inhibiting GPBP activity, making them useful as therapeutics in antibody-mediated disorders, drug-resistant cancer, inflammation, protein misfolding and ER stress-mediated disorders, and aberrant apoptosis.
本发明揭示了一种公式为的化合物:抑制GPBP活性,使它们在抗体介导的疾病、耐药性癌症、炎症、蛋白质错折和ER应激介导的疾病以及异常细胞凋亡中有用作为治疗药物。